DE60219922D1 - Neue salze von verbindungen mit antikrampfwirkung - Google Patents

Neue salze von verbindungen mit antikrampfwirkung

Info

Publication number
DE60219922D1
DE60219922D1 DE60219922T DE60219922T DE60219922D1 DE 60219922 D1 DE60219922 D1 DE 60219922D1 DE 60219922 T DE60219922 T DE 60219922T DE 60219922 T DE60219922 T DE 60219922T DE 60219922 D1 DE60219922 D1 DE 60219922D1
Authority
DE
Germany
Prior art keywords
antique
compounds
new salts
ramping effect
ramping
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60219922T
Other languages
English (en)
Other versions
DE60219922T2 (de
Inventor
Ahmed Abdel-Magid
Cynthia Maryanoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23174444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60219922(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE60219922D1 publication Critical patent/DE60219922D1/de
Publication of DE60219922T2 publication Critical patent/DE60219922T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE60219922T 2001-07-09 2002-07-03 Neue salze von verbindungen mit antikrampfwirkung Expired - Lifetime DE60219922T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30396201P 2001-07-09 2001-07-09
US303962P 2001-07-09
PCT/US2002/021016 WO2003006467A1 (en) 2001-07-09 2002-07-03 Novel anticonvulsant derivative salts

Publications (2)

Publication Number Publication Date
DE60219922D1 true DE60219922D1 (de) 2007-06-14
DE60219922T2 DE60219922T2 (de) 2008-01-17

Family

ID=23174444

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60219922T Expired - Lifetime DE60219922T2 (de) 2001-07-09 2002-07-03 Neue salze von verbindungen mit antikrampfwirkung

Country Status (27)

Country Link
US (2) US7098188B2 (de)
EP (1) EP1414824B1 (de)
JP (1) JP2005502629A (de)
KR (1) KR20040013127A (de)
CN (1) CN1288159C (de)
AR (1) AR036137A1 (de)
AT (1) ATE361304T1 (de)
AU (1) AU2002346042B2 (de)
BR (1) BR0211063A (de)
CA (1) CA2452612A1 (de)
DE (1) DE60219922T2 (de)
DK (1) DK1414824T3 (de)
ES (1) ES2284884T3 (de)
HK (1) HK1064094A1 (de)
HR (1) HRP20040017A2 (de)
HU (1) HUP0401080A2 (de)
IL (2) IL159698A0 (de)
MX (1) MXPA04000232A (de)
NO (1) NO20040066L (de)
NZ (1) NZ530507A (de)
PL (1) PL367635A1 (de)
PT (1) PT1414824E (de)
RU (1) RU2320665C2 (de)
SI (1) SI21370A (de)
UA (1) UA78211C2 (de)
WO (1) WO2003006467A1 (de)
ZA (1) ZA200400970B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78211C2 (en) 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US7041650B2 (en) 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
EP1450826A1 (de) * 2001-11-06 2004-09-01 Ortho-Mcneil Pharmaceutical Corp. Behandlung und prävention von parästhesie, umfassend eine begleittherapie mit antikonvulsiven derivaten und kalium
WO2004000284A1 (en) * 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US9489372B2 (en) * 2013-03-15 2016-11-08 Apple Inc. Web-based spell checker
TWI826531B (zh) 2018-09-21 2023-12-21 南韓商愛思開生物製藥股份有限公司 具有㗁二唑之化合物及包含該化合物之醫藥組合物
US20210169844A1 (en) 2019-12-10 2021-06-10 Tulex Pharmaceuticals Inc. Compositions and methods for treating epilepsy, seizures and other conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
PT1158973E (pt) * 1999-02-24 2005-07-29 Univ Cincinnati Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate

Also Published As

Publication number Publication date
ES2284884T3 (es) 2007-11-16
RU2320665C2 (ru) 2008-03-27
AU2002346042B8 (en) 2003-01-29
CN1551882A (zh) 2004-12-01
KR20040013127A (ko) 2004-02-11
IL159698A (en) 2009-09-22
CA2452612A1 (en) 2003-01-23
AR036137A1 (es) 2004-08-11
RU2004100274A (ru) 2005-06-20
PL367635A1 (en) 2005-03-07
UA78211C2 (en) 2007-03-15
BR0211063A (pt) 2004-07-20
AU2002346042B2 (en) 2007-10-18
NZ530507A (en) 2007-01-26
US7098188B2 (en) 2006-08-29
DK1414824T3 (da) 2007-07-16
NO20040066L (no) 2004-03-01
HUP0401080A2 (hu) 2004-09-28
PT1414824E (pt) 2007-06-27
DE60219922T2 (de) 2008-01-17
US20060105966A1 (en) 2006-05-18
WO2003006467A1 (en) 2003-01-23
SI21370A (sl) 2004-06-30
HK1064094A1 (en) 2005-01-21
JP2005502629A (ja) 2005-01-27
EP1414824B1 (de) 2007-05-02
ATE361304T1 (de) 2007-05-15
CN1288159C (zh) 2006-12-06
ZA200400970B (en) 2005-02-07
EP1414824A1 (de) 2004-05-06
HRP20040017A2 (en) 2004-10-31
MXPA04000232A (es) 2005-03-07
IL159698A0 (en) 2004-06-20
US20030069190A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
DE60219922D1 (de) Neue salze von verbindungen mit antikrampfwirkung
DE60321324D1 (de) Sulfonylaminoderivate als neue inhibitoren von histondeacetylase
DK1355644T3 (da) Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
DE50212273D1 (de) Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen
IS7728A (is) Aðferð til að framleiða kalsíumsalt rósuvastatíns
DE60112811D1 (de) Neue photochrome indenonaphthopyranverbindungen
DE60126611D1 (de) Ditosylatsalze von chinazolinverbindungen
ATE286036T1 (de) Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren
DE60207161T2 (de) Halbleiteranordnung mit Hardware-Anordnung zur Taktsteuerung
ATE296619T1 (de) Feste orale dosierungsform von simethicon
ATE425947T1 (de) Neue difunktionelle fotoinitiatoren
DE60215616D1 (de) Quarternäre ammoniumverbindungen enthaltende konservierungsmittelmischungen
DE60327443D1 (de) Neue oxazolverbindungen als inhibitoren des transforming growth factor (tgf)
DE60006561D1 (de) Hydroformylierung mit hilfe von mehrzähnigen phosphit-liganden
DE60330362D1 (de) Neue pyrazol-verbindungen als hemmer des transformierenden wachstumsfaktors (tgf)
IS7287A (is) Pýrimídín efnasambönd
DE69901840D1 (de) Neue salzform von pantoprazol
IS6868A (is) Ný pýrimidínefnasambönd
ATE323081T1 (de) N-formylhydroxylamin verbindungen als inhibitoren von pdf
IS7166A (is) Notkun annellataðra pýrrólsambanda í meðhöndlun áliðabrjósks- eða neðanbrjósksbeinahrörnun
IS6732A (is) Bísýklísk heteróarómatísk efnasambönd
NO20035153D0 (no) Karbapenemforbindelse
ATE405574T1 (de) Aryl-annellierte azapolyzyklische verbindungen
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
DE60126125D1 (de) Neue carbapenem-derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition